Cyclopentanamine

Cyclopentanamine

SCHEMBL9979148

NC1CCCC1.NC1CCCC1.O=C(O)c1ccc(C(=O)NC2CCCC2)c2c(C(=O)O)ccc(C(=O)NC3CCCC3)c12

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.49
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
HPGD P15428 2/20 0.48
HTT P42858 2/20 0.48
MAOA P21397 2/20 0.45
KDM1A O60341 1/20 0.45
MAPT P10636 2/20 0.44
SMYD3 Q9H7B4 1/20 0.44
PKM P14618 1/20 0.44
GLA P06280 1/20 0.44
MAPK1 P28482 1/20 0.44
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexylamine SCHEMBL9979064 0.98 NPC1 (0.50) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL822571 0.92 GAA (0.55) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL12021895 0.92 GAA (0.55) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL5053780 0.92 GAA (0.55) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL2159871 0.91 NPC1 (0.57) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL12021902 0.91 NPC1 (0.57) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL823228 0.91 NPC1 (0.57) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL822757 0.86 GAA (0.50) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL4930405 0.85 NPC1 (0.51) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL823149 0.85 NPC1 (0.51) GAAALDH1A1KDM4ELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450726-B2 Articles containing coatings of amic acid salts EASTMAN KODAK COMPANY (US) 2013-05-28 US disclosed
US-8431433-B2 Methods of providing semiconductor layers from amic acid salts EASTMAN KODAK COMPANY (US) 2013-04-30 US disclosed
EP-2576501-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS Eastman Kodak Company (US) 2013-04-10 EP disclosed
US-8404892-B2 Aromatic amic acid salts and compositions EASTMAN KODAK COMPANY (US) 2013-03-26 US disclosed
WO-2011149699-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS EASTMAN KODAK COMPANY (US) 2011-12-01 WO disclosed
US-20110294257-A1 METHODS OF PROVIDING SEMICONDUCTOR LAYERS FROM AMIC ACID SALTS KODAK AMERICAS LTD. 2011-12-01 US disclosed
US-20110295010-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS FPC INC. 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295010-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS DDC, MYOC, TNNC1 GAA 2763/4885ALDH1A1 1563/4885KDM4E 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.